Oren Gilad
NIH Rank #12992
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10892297Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$1.1M
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#12,992
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $1.1M in linked award amounts across 1 award record · Award-linked rank #12992.
FY2024 award records by amount
NIH award records listing Oren Gilad as a PI. Multi-PI records show the full award amount for context.
- 5R44CA278078-02R44Development of a first-in-class combination of DNA damage response inhibitors for the treatment of high-grade serous ovarian cancer$1.1Maward amount
Award organization
Organizations that administered FY2024 awards listing Oren Gilad as a PI.
FY2024 award administered by Aprea Therapeutics, Inc. (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Oren Gilad.